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1. Introduction 
To investigate the structure-activity relationship 
of an antibiotically active tripeptide (the sequence 
of which is L-Arg-D-aThr-L-Phe) isolated by KiSnig 
et al. [1 ], a sequence variation approach was used. 
Earlier experiments showed, that D-allo-threonine 
could be substituted in the above sequence by a 
numberof other D-amino acids without total loss of 
antibiotic activity [2]. It was hence of interest o 
find out if the replacement of D-allo-threonine by 
N-a-methyl-L-amino acids (which are found in some 
peptide antibiotics) would also lead to antibiotically 
active tripeptides. It was also of interest whether the 
action of these peptides could also be neutralized by 
L-amino acids as was shown [2] for the peptides with 
D-amino acids. These experiments should also clarify 
whether the conformation of these tripeptides (which 
is quite different from those with a middle D-amino 
acid) must be specific or not. 
2. Materials and methods 
The peptides were synthesised in the solid phase 
and purified by column chromatography on silica gel 
at 4°C, using n-butanol: H20: glacial acetic acid = 
4 :2 :1 .  
The N-a-methyl-L-amino acids were prepared 
according to [3], the Boc-amino acids* to [4] and 
* Abbreviations: Boc = tert. butyloxycarbonyl, DMF = 
dimethylformamide, EtOH = ethanol, Me = methyl, Z = 
benzyloxycarbonyl, Z3L-Arg = tris(benzyloxycarbonyl)- 
L-arginine. 
Za-L-arginine to [5]. Test-organisms u ed were those 
described by K/Snig et al. [1 ] (Paecilomyce s variotL 
Mucor michel Bacillus subtilis and E. coli). The plate 
diffusion test followed the method in [6], complex 
medium ~,as prepared according to [7] and the cross- 
stripe test followed the method of [8]. Pathogenic 
moulds used were Trichophyton mentagrophytes and 
Epidermophyton floccosum. 
3. Results and discussion 
The tripeptides synthesised, together with their 
analytical data, are shown in table 1. 
Six of the peptides ynthesised showed antibiotic 
activity on fungi and on the pathogenic moulds used 
(table 2) but none towards Gram positive and Gram 
negative bacteria. These facts agree with the results 
described by K6nig et al. [1 ] for the isolated peptide 
(L-Arg-D-aThr-L-Phe) and with those of the 
synthetic peptides, where D-allo-threonine is replaced 
by other D-amino acids [2]. 
The results of the biological tests agree with those 
of earlier works [1,2] in the following points: 
1) The antibiotic activity increases with the lipo- 
philicity of the amino acid used for the replace- 
ment of D-allo-threonine. 
2) Trifunctional, aliphatic amino acids used for the 
replacement of D-allo-threonine yield inactive 
tripeptides. 
3) The results of the cross-stripe t st show that the 
middle amino acid in the tripeptides most probably 
determines the activity. 
As the tripeptides with an N-a-Me-L-amino acid in 
their middle positions yield the same results in the 
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Table 1 
Synthetic tripeptides 
Peptide Yield, %* N,% as462° Amino acid Formulae 
analyses* * 2O Ot578 
c=l  in 
water 
L-Arg-L-MeAIa-L-Phe 50 calc. -33 .0  Arg 0.96 C~ 9H3oN604 .HBr 
17.24 MeAla - MW: 487.4 
found Phe 1.00 
17.13 
L-Arg- L-MeGIu- L-Phe 56 calc. - t 8.0 Arg 0.98 C2 ~ H32 N604 • H Br 
15.41 -16 .5  MeGlu - MW: 545.5 
found Phe 1.00 
15.33 
L-Arg- L-Melle- L-Phe 52.8 calc. -41 .0  Arg 1.02 C2 ~ H36 N604 "HBr 
15.87 Melle - MW: 529.5 
found Phe 1.00 
15.75 
L-Arg- L-MeLeu-L-Phe 61.3 calc. + 15.0 Arg 0.98 C22 H36 N604 "HBr 
15.87 +13.0 MeLeu - MW: 529.5 
found Phe 1.00 
15.77 
L-Arg- L-Me Ph e - L-Phe 58.7 calc. - 15.0 Arg 1.02 C25 H 36 N 6 O 4" H Br 
14.92 -17 .0  MePhe - MW: 563.5 
found Phe 1.00 
14.83 
L -Arg -Sar -  L-Phe 77.2 calc. +20.5 Arg 0.96 CxsH28N604 .HBr 
17.75 +25.5 Sar - MW: 473.4 
found Phe 1.00 
17.62 
L-Arg- L-MeSer- L-Phe 56.9 calc. + 12.0 Arg 0.95 C19 Ha oNeOs'HBr 
16.70 +10.5 MeSer - MW: 503.4 
found Phe 1.00 
16.59 
L-Arg-L-MeThr-L-Phe 67 calc. -27 .0  Arg 1.01 C:oH3~N~O s .HBr 
16.24 -25 .0  MeThr - MW: 517.4 
found Phe 1.00 
16.09 
L-Arg- L-MeVal-L-Phe 73.1 calc. -48 .0  Arg 0.93 C21 Ha4N604"HBr 
16.30 -42 .0  MeVal - MW: 515.5 
found Phe 1.00 
16.12 
* The yield is related to the first amino acid on the resin support, and was precipitated from EtOH/ether in each case. 
** L-Methyl amino acids not determined. 
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Table 2 
Antibiotic activity of synthetic tripeptides 
Peptide Minimal* Cross-stripe test 
inhibitory 
concn., Neutralizing 
mg/ml amino acid 
Neutralizing 
ratio 
L-Arg- L-MeAIa- L-Phe 2.1 L-Ala 1 : 1 
L-Arg-Sar-L-Phe 1.5 none found - 
L-Arg- L-MeVal- L-Phe 0.48 L-Val 1 : 3 
L-Arg- L-Me Leu - L-Phe 0.45 L-Leu 1:4 
L-Arg-L-MePhe-Lophe 0.22 L-Phe 1:5 
L-Arg- L-Melle- L-Phe 0.20 L-lie 1 : 6 
L-Arg-L-MeGIu-L-Phe, L-Arg-L-MeSer-L-Phe and L-Arg-L-MeThr-L-Phe were 
not inhibitory. 
* Inhibition tested on Paecilomyces varioti. 
biological test as those with a D-amino acid in this 
position, the conclusion can be drawn, that a special 
conformat ion is not essential for antibiotic activity 
of  tr ipeptides of  general sequence L -Arg -X -DPhe.  
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